REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 120 filers reported holding REVOLUTION MEDICINES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $913,329 | -25.5% | 32,996 | -28.0% | 0.00% | -50.0% |
| Q2 2023 | $1,225,926 | +23.5% | 45,829 | 0.0% | 0.01% | +200.0% |
| Q1 2023 | $992,656 | -26.6% | 45,829 | -19.3% | 0.00% | -33.3% |
| Q4 2022 | $1,352,309 | +20.7% | 56,772 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $1,120,000 | -26.3% | 56,772 | -27.2% | 0.00% | -25.0% |
| Q2 2022 | $1,519,000 | -39.9% | 77,931 | -21.4% | 0.00% | -20.0% |
| Q1 2022 | $2,528,000 | +1.4% | 99,104 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $2,494,000 | -8.5% | 99,104 | 0.0% | 0.01% | -28.6% |
| Q3 2021 | $2,726,000 | -17.2% | 99,104 | -4.4% | 0.01% | -22.2% |
| Q2 2021 | $3,292,000 | -30.8% | 103,702 | 0.0% | 0.01% | -40.0% |
| Q1 2021 | $4,758,000 | +10.1% | 103,702 | -5.0% | 0.02% | +7.1% |
| Q4 2020 | $4,322,000 | -7.2% | 109,179 | -18.4% | 0.01% | -22.2% |
| Q3 2020 | $4,655,000 | – | 133,776 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 4,839,529 | $133,958,163 | 40.59% |
| Column Group LLC | 1,230,641 | $34,064,143 | 22.62% |
| Boxer Capital, LLC | 4,684,264 | $129,660,428 | 6.90% |
| Finepoint Capital LP | 427,000 | $11,819,360 | 5.89% |
| Casdin Capital, LLC | 1,810,000 | $50,100,800 | 5.54% |
| EcoR1 Capital, LLC | 5,577,863 | $154,395,248 | 5.21% |
| DAFNA Capital Management LLC | 473,394 | $13,103,546 | 4.08% |
| Artal Group S.A. | 2,529,737 | $70,023 | 3.00% |
| BVF INC/IL | 3,981,212 | $110,199,948 | 2.97% |
| Bellevue Group AG | 4,721,500 | $130,691,120 | 2.11% |